PCL, Inc. (241820)의 가격은 얼마입니까?

PCL, Inc. (241820)의 가격은 $0.21291741입니다.

PCL, Inc. (241820)의 시가 총액은 무엇입니까?

PCL, Inc. (241820)의 시가 총액은 $12.07M입니다.

PCL, Inc. (241820) 발행주식수

PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic (IVD) solutions, encompassing both diagnostic products and specialized platform services. The company's primary offerings include comprehensive multiplex kits designed to detect antibodies to Human Immunodeficiency Virus (HIV) types 1 and 2, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human T-lymphotropic Virus (HTLV) types 1 and 2. These kits also identify specific antigens such as HIV p24, HCV core, and HBV surface markers in human serum or plasma samples. In addition to these, PCL markets Ai, a rapid diagnostic test kit capable of typing influenza A and B strains; Cancer6, a screening kit for multiple tumor biomarkers; and the sciLINER LATERAL FLOW DISPENSER, an advanced dispensing device for membrane materials featuring active visual drop volume control. Beyond its product portfolio, PCL offers valuable platform services. These include a sol-gel spotting service, which immobilizes client-specified materials using the proprietary SolB reagent, and an SG ID service, providing customers with identified molecules of interest securely immobilized within the SolB reagent. PCL, Inc. is headquartered in Seoul, South Korea.

연도	발행 주식 수	변화
2026 (TTM)	2.78M	-95.05%
2024	56.15M	38.25%
2023	40.62M	14.64%
2022	35.43M	4.04%
2021	34.05M	5.39%
2020	32.31M	6.30%
2019	30.40M	1.18%
2018	30.04M	2.72%
2017	29.25M	-2.51%
2016	30.00M	0.00%
2015	30.00M	0.00%

연도

발행 주식 수

변화

2026 (TTM)

2.78M

-95.05%

2024

56.15M

38.25%

2023

40.62M

14.64%

2022

35.43M

4.04%

2021

34.05M

5.39%

2020

32.31M

6.30%

2019

30.40M

1.18%

2018

30.04M

2.72%

2017

29.25M

-2.51%

2016

30.00M

0.00%

2015

30.00M

0.00%

회사	발행 주식 수	차이	국가
Abbott Laboratories ABT.US	1.74B	62,552.16%	US
Stryker Corporation SYK.US	383.50M	13,684.52%	US
Medtronic plc MDT.US	1.28B	45,983.78%	IE
Boston Scientific Corporation BSX.US	1.48B	53,010.83%	US
Edwards Lifesciences Corporation EW.US	576.40M	20,618.11%	US

회사

발행 주식 수

차이

국가